Skip to main content

Viking Therapeutics, Inc.

VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001607678

In the last 90 days, Viking Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 437 institutions reported holding it in 13F filings for Q2 2026, worth $2.96B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Viking Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
−2 vs. Q2 2021
Shares held
37.8M
−97.1K (−0.3%) vs. Q2 2021
Total value
$237.7M
+$10.8M (+4.8%) vs. Q2 2021
New holders
10
40 more added
Sold out
12
47 more reduced

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 135 institutions
Q1 2021: 144 institutionsQ2 2021: 138 institutionsQ3 2021: 135 institutionsQ4 2021: 140 institutionsQ1 2022: 140 institutionsQ2 2022: 115 institutionsQ3 2022: 107 institutionsQ4 2022: 129 institutionsQ1 2023: 185 institutionsQ2 2023: 193 institutionsQ3 2023: 179 institutionsQ4 2023: 197 institutionsQ1 2024: 373 institutionsQ2 2024: 388 institutionsQ3 2024: 422 institutionsQ4 2024: 409 institutionsQ1 2025: 373 institutionsQ2 2025: 392 institutionsQ3 2025: 371 institutionsQ4 2025: 427 institutionsQ1 2026: 414 institutionsQ2 2026: 437 institutions
Value heldQ3 2021: $237.7M
Q1 2021: $259.3MQ2 2021: $226.9MQ3 2021: $237.7MQ4 2021: $166.5MQ1 2022: $93.8MQ2 2022: $77.2MQ3 2022: $72.4MQ4 2022: $319.7MQ1 2023: $1.11BQ2 2023: $1.21BQ3 2023: $854.0MQ4 2023: $1.42BQ1 2024: $6.56BQ2 2024: $4.26BQ3 2024: $5.27BQ4 2024: $3.30BQ1 2025: $1.88BQ2 2025: $2.02BQ3 2025: $1.87BQ4 2025: $2.54BQ1 2026: $2.43BQ2 2026: $2.96B
Institutions holding VKTX and their total value by quarter
QuarterHoldersValue
Q2 2026437$2.96B
Q1 2026414$2.43B
Q4 2025427$2.54B
Q3 2025371$1.87B
Q2 2025392$2.02B
Q1 2025373$1.88B
Q4 2024409$3.30B
Q3 2024422$5.27B
Q2 2024388$4.26B
Q1 2024373$6.56B
Q4 2023197$1.42B
Q3 2023179$854.0M
Q2 2023193$1.21B
Q1 2023185$1.11B
Q4 2022129$319.7M
Q3 2022107$72.4M
Q2 2022115$77.2M
Q1 2022140$93.8M
Q4 2021140$166.5M
Q3 2021135$237.7M
Q2 2021138$226.9M
Q1 2021144$259.3M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Viking Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding VKTX in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC124,045$779.0K0.00%−59,285−32.3%Reduced
Rafferty Asset Management, LLC131,404$825.0K0.01%−54,032−29.1%Reduced
Bank of Montreal126,642$849.0K0.00%−17,065−11.9%Reduced
Employees Retirement System of Texas138,826$872.0K0.01%00.0%Unchanged
Goldman Sachs Group Inc140,611$883.0K0.00%−151,370−51.8%Reduced
Blair William & Co145,181$912.0K0.00%−11,555−7.4%Reduced
Swiss National Bank155,300$975.0K0.00%+10,100+7.0%Added
Charles Schwab Investment Management Inc172,095$1.08M0.00%+556+0.3%Added
Raymond James Financial Services Advisors, Inc.181,523$1.14M0.00%+18,860+11.6%Added
Susquehanna International Group, LLP191,765$1.20M0.00%−63,393−24.8%Reduced
Knott David M208,102$1.31M0.54%00.0%Unchanged
Raymond James & Associates251,336$1.58M0.00%−8,085−3.1%Reduced
Morgan Stanley257,739$1.62M0.00%−190,852−42.5%Reduced
Bank of New York Mellon Corp266,352$1.67M0.00%+16,191+6.5%Added
UBS Group AG270,814$1.70M0.00%+102,785+61.2%Added
Deutsche Bank AG280,954$1.76M0.00%−2,685−0.9%Reduced
New York State Common Retirement Fund287,173$1.80M0.00%−14,969−5.0%Reduced
Bank of America Corp292,582$1.84M0.00%+14,839+5.3%Added
Parametric Portfolio Associates LLC309,936$1.95M0.00%+5,634+1.9%Added
Macquarie Group Ltd332,048$2.08M0.00%00.0%Unchanged
DAFNA Capital Management LLC447,400$2.81M0.75%00.0%Unchanged
Ikarian Capital, LLC500,642$3.14M0.72%−24,112−4.6%Reduced
Sio Capital Management, LLC660,813$4.15M1.34%+41,033+6.6%Added
Dimensional Fund Advisors LP766,723$4.82M0.00%+430,845+128.3%Added
Two Sigma Investments, LP876,324$5.50M0.01%+48,380+5.8%Added
Two Sigma Advisers, LP938,828$5.90M0.02%−45,400−4.6%Reduced
Northern Trust Corp973,507$6.11M0.00%−26,294−2.6%Reduced
Fiera Capital Corp1,069,010$6.71M0.02%−16,386−1.5%Reduced
Nuveen Asset Management, LLC1,113,372$7.45M0.00%+829,824+292.7%Added
Geode Capital Management, LLC1,187,322$7.46M0.00%+26,997+2.3%Added
Park West Asset Management LLC1,668,587$10.5M0.30%00.0%Unchanged
Vanguard Group Inc3,364,952$21.1M0.00%+84,142+2.6%Added
State Street Corp4,042,251$25.4M0.00%−943,709−18.9%Reduced
BlackRock Inc.5,121,133$32.2M0.00%−118,917−2.3%Reduced
ArrowMark Colorado Holdings LLC7,993,211$50.2M0.39%+322,659+4.2%Added
ACT Capital Management, LLC0$00.00%−128,500−100.0%Sold out
XTX Topco Ltd0$00.00%−24,841−100.0%Sold out
Virtu Financial LLC0$00.00%−22,929−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−21,810−100.0%Sold out
ProShare Advisors LLC0$00.00%−17,747−100.0%Sold out
Hayden Royal, LLC0$00.00%−16,900−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−16,273−100.0%Sold out
Virginia Retirement Systems Et Al0$00.00%−12,700−100.0%Sold out
Advisory Services Network, LLC0$00.00%−500−100.0%Sold out
Signaturefd, LLC0$00.00%−191−100.0%Sold out
Berman Capital Advisors, LLC0$00.00%−38−100.0%Sold out
State of Wyoming0$00.00%−31−100.0%Sold out
CWM, LLC––––Not filed